Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
|
|
Astex Pharmaceuticals, Inc (ASTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2014 |
SC 13G/A
| APAX PARTNERS EUROPE MANAGERS LTD reports a 0% stake in Astex Pharmaceuticals, Inc. |
| 10/16/2013 |
4
| LACK WALTER J (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Unknown transaction of 457,500 shares
@ $0
Disposed/sold 22,500 options to buy
@ $7.79, valued at
$175.3k
Disposed/sold 30,000 options to buy
@ $5.89, valued at
$176.7k
Disposed/sold 45,000 options to buy
@ $2.1, valued at
$94.5k
Disposed/sold 45,000 options to buy
@ $4.6, valued at
$207k
|
|
| 10/16/2013 |
4
| Kola Ismail (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Disposed/sold 26,192 options to buy
@ $0.92, valued at
$24.1k
Disposed/sold 50,000 options to buy
@ $2.94, valued at
$147k
Disposed/sold 20,000 options to buy
@ $2.1, valued at
$42k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
|
|
| 10/16/2013 |
4
| Haines Timothy (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Disposed/sold 50,000 options to buy
@ $2.94, valued at
$147k
Disposed/sold 32,500 options to buy
@ $2.1, valued at
$68.3k
Disposed/sold 32,500 options to buy
@ $4.6, valued at
$149.5k
|
|
| 10/16/2013 |
4
| Goldberg Allan R (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Disposed/sold 50,000 options to buy
@ $4.89, valued at
$244.5k
Disposed/sold 7,500 options to buy
@ $4.84, valued at
$36.3k
Disposed/sold 10,000 options to buy
@ $3.97, valued at
$39.7k
Disposed/sold 8,889 options to buy
@ $3.65, valued at
$32.4k
Disposed/sold 10,000 options to buy
@ $5.89, valued at
$58.9k
Disposed/sold 8,621 options to buy
@ $4.03, valued at
$34.7k
Disposed/sold 10,000 options to buy
@ $2.01, valued at
$20.1k
Disposed/sold 12,658 options to buy
@ $1.89, valued at
$23.9k
Disposed/sold 10,000 options to buy
@ $1.98, valued at
$19.8k
Disposed/sold 10,204 options to buy
@ $2.7, valued at
$27.6k
Disposed/sold 7,500 options to buy
@ $3.26, valued at
$24.5k
|
|
| 10/16/2013 |
4
| GIRARDI THOMAS V (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Unknown transaction of 348,500 shares
@ $0
Disposed/sold 22,500 options to buy
@ $7.79, valued at
$175.3k
Disposed/sold 10,000 options to buy
@ $5.88, valued at
$58.8k
Disposed/sold 22,500 options to buy
@ $4.84, valued at
$108.9k
Disposed/sold 30,000 options to buy
@ $3.97, valued at
$119.1k
Disposed/sold 30,000 options to buy
@ $5.89, valued at
$176.7k
Disposed/sold 30,000 options to buy
@ $2.01, valued at
$60.3k
Disposed/sold 30,000 options to buy
@ $1.98, valued at
$59.4k
Disposed/sold 35,000 options to buy
@ $2.14, valued at
$74.9k
Disposed/sold 35,000 options to buy
@ $2.92, valued at
$102.2k
Disposed/sold 45,000 options to buy
@ $2.1, valued at
$94.5k
|
|
| 10/16/2013 |
4
| Fellner Peter (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Disposed/sold 50,000 options to buy
@ $2.94, valued at
$147k
Disposed/sold 20,000 options to buy
@ $2.1, valued at
$42k
Disposed/sold 20,000 options to buy
@ $4.6, valued at
$92k
|
|
| 10/16/2013 |
4
| CASAMENTO CHARLES J (Director) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Disposed/sold 15,000 options to buy
@ $7.79, valued at
$116.9k
Disposed/sold 10,000 options to buy
@ $5.88, valued at
$58.8k
Disposed/sold 15,000 options to buy
@ $4.84, valued at
$72.6k
Disposed/sold 20,000 options to buy
@ $3.97, valued at
$79.4k
Disposed/sold 20,000 options to buy
@ $5.89, valued at
$117.8k
Disposed/sold 7,500 options to buy
@ $3.26, valued at
$24.5k
Disposed/sold 35,000 options to buy
@ $2.14, valued at
$74.9k
Disposed/sold 25,000 options to buy
@ $2.92, valued at
$73k
Disposed/sold 833 options to buy
@ $2.92, valued at
$2.4k
Disposed/sold 32,500 options to buy
@ $4.6, valued at
$149.5k
|
|
| 10/16/2013 |
4
| MOLKENTIN MICHAEL (CFO) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Unknown transaction of 28,874 shares
@ $0
Disposed/sold 25,000 options to buy
@ $4.89, valued at
$122.3k
Disposed/sold 60,000 options to buy
@ $5.1, valued at
$306k
Disposed/sold 42,750 options to buy
@ $5.32, valued at
$227.4k
Disposed/sold 96,000 options to buy
@ $2.35, valued at
$225.6k
Disposed/sold 67,500 options to buy
@ $1.65, valued at
$111.4k
Disposed/sold 110,000 options to buy
@ $3.23, valued at
$355.3k
Disposed/sold 150,000 options to buy
@ $2.78, valued at
$417k
Disposed/sold 160,000 options to buy
@ $1.89, valued at
$302.4k
Disposed/sold 160,000 options to buy
@ $2.71, valued at
$433.6k
|
|
| 10/16/2013 |
4
| Buckland Martin (Chief Business Officer) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Unknown transaction of 5,963 shares
@ $0
Disposed/sold 52,384 options to buy
@ $0.7, valued at
$36.7k
Disposed/sold 26,192 options to buy
@ $0.84, valued at
$22k
Disposed/sold 19,644 options to buy
@ $0.87, valued at
$17.1k
Disposed/sold 26,192 options to buy
@ $0.73, valued at
$19.1k
Disposed/sold 32,085 options to buy
@ $0.79, valued at
$25.3k
Disposed/sold 98,220 options to buy
@ $0.92, valued at
$90.4k
Disposed/sold 150,000 options to buy
@ $2.21, valued at
$331.5k
Disposed/sold 180,000 options to buy
@ $1.89, valued at
$340.2k
Disposed/sold 180,000 options to buy
@ $2.71, valued at
$487.8k
|
|
| 10/16/2013 |
4
| AZAB MOHAMMAD (Chief Medical Officer) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Unknown transaction of 8,753 shares
@ $0
Disposed/sold 260,000 options to buy
@ $2.58, valued at
$670.8k
Disposed/sold 60,000 options to buy
@ $3.23, valued at
$193.8k
Disposed/sold 280,000 options to buy
@ $2.78, valued at
$778.4k
Disposed/sold 200,000 options to buy
@ $1.89, valued at
$378k
Disposed/sold 300,000 options to buy
@ $2.71, valued at
$813k
|
|
| 10/16/2013 |
4
| Jhoti Harren (President) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Unknown transaction of 45,163 shares
@ $0
Unknown transaction of 16,084 shares
@ $0
Disposed/sold 8,792 options to buy
@ $0.84, valued at
$7.4k
Disposed/sold 26,192 options to buy
@ $0.87, valued at
$22.8k
Disposed/sold 65,480 options to buy
@ $0.68, valued at
$44.5k
Disposed/sold 38,633 options to buy
@ $0.79, valued at
$30.5k
Disposed/sold 111,316 options to buy
@ $0.92, valued at
$102.4k
Disposed/sold 300,000 options to buy
@ $2.21, valued at
$663k
Disposed/sold 210,000 options to buy
@ $1.89, valued at
$396.9k
Disposed/sold 210,000 options to buy
@ $2.71, valued at
$569.1k
|
|
| 10/16/2013 |
4
| MANUSO JAMES S J (CEO) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Unknown transaction of 13,900 shares
@ $0
Unknown transaction of 70 shares
@ $0
Disposed/sold 250,000 options to buy
@ $6.1, valued at
$1.5M
Disposed/sold 250,000 options to buy
@ $5.03, valued at
$1.3M
Disposed/sold 200,000 options to buy
@ $4.87, valued at
$974k
Disposed/sold 360,000 options to buy
@ $5.06, valued at
$1.8M
Disposed/sold 1,000,000 options to buy
@ $5.06, valued at
$5.1M
Disposed/sold 360,000 options to buy
@ $3.6, valued at
$1.3M
Disposed/sold 360,000 options to buy
@ $2, valued at
$720k
Disposed/sold 1,200,000 options to buy
@ $1.76, valued at
$2.1M
Disposed/sold 360,000 options to buy
@ $3.12, valued at
$1.1M
|
|
| 10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/11/2013 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 10/11/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/11/2013 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/10/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/09/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/08/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/08/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements: |
| 10/07/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 10/07/2013 |
SC TO-T/A
| Form SC TO-T - Tender offer statement by Third Party [amend] |
| 09/06/2013 |
4
| MANUSO JAMES S J (CEO) has filed a Form 4 on Astex Pharmaceuticals, Inc|
Txns:
| Exercised 7,500 options to buy
@ $5.69, valued at
$42.7k
|
|
| 09/05/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 09/05/2013 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 09/05/2013 |
8-K
| Quarterly results |
| 08/09/2013 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
| 08/09/2013 |
10-Q
| Quarterly Report for the period ended June 30, 2013 |
|
|
|